thromboangiitis obliterans
thromboangiitis obliterans
Explore linked clinical trials. Standard reference: MONDO:00088894 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease | Arterial Occlusive Diseases, Embolism and Thrombosis, Raynaud disease, Skin and Connective Tissue Diseases, cardiovascular disorder, livedoid vasculopathy, peripheral vascular disease, skin disorder, skin vascular disease, thromboangiitis obliterans, thrombotic disease, vascular disorder, vasculitis | Not yet recruiting | Phase 3 | 2026-07-23 | NCT05698979 | |
| A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers | Arterial Occlusive Diseases, Chemically-Induced Disorders, cardiovascular disorder, nicotine dependence, psychiatric disorder, substance-related disorder, thromboangiitis obliterans, vascular disorder, vasculitis | Recruiting | Phase 1 | 2025-10-15 | NCT07215923 | |
| Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, thromboangiitis obliterans, vascular disorder, vasculitis | Recruiting | Phase 4 | 2025-09-09 | NCT05854615 | |
| Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Diabetes Complications, Diabetic Foot, Disease Attributes, Foot Ulcer, Leg Ulcer, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, arteriosclerosis disorder, arteriosclerosis obliterans, atherosclerosis, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, skin disorder, thromboangiitis obliterans, vascular disorder, vasculitis | Enrolling by invitation | Not stated | 2025-07-11 | NCT07023965 |